RT Journal Article
SR Electronic
T1 A Vital Sign-based Prediction Algorithm for Differentiating COVID-19 Versus Seasonal Influenza in Hospitalized Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.13.21249540
DO 10.1101/2021.01.13.21249540
A1 Yanamala, Naveena
A1 Krishna, Nanda H.
A1 Hathaway, Quincy A.
A1 Radhakrishnan, Aditya
A1 Sunkara, Srinidhi
A1 Patel, Heenaben
A1 Farjo, Peter
A1 Patel, Brijesh
A1 Sengupta, Partho P
YR 2021
UL http://medrxiv.org/content/early/2021/01/15/2021.01.13.21249540.abstract
AB Patients with influenza and SARS-CoV2/Coronavirus disease 2019 (COVID-19) infections have different clinical course and outcomes. We developed and validated a supervised machine learning pipeline to distinguish the two viral infections using the available vital signs and demographic dataset from the first hospital/emergency room encounters of 3,883 patients who had confirmed diagnoses of influenza A/B, COVID-19 or negative laboratory test results. The models were able to achieve an area under the receiver operating characteristic curve (ROC AUC) of at least 97% using our multiclass classifier. The predictive models were externally validated on 15,697 encounters in 3,125 patients available on TrinetX database that contains patient-level data from different healthcare organizations. The influenza vs. COVID-19-positive model had an AUC of 98%, and 92% on the internal and external test sets, respectively. Our study illustrates the potentials of machine-learning models for accurately distinguishing the two viral infections. The code is made available at https://github.com/ynaveena/COVID-19-vs-Influenza and may be have utility as a frontline diagnostic tool to aid healthcare workers in triaging patients once the two viral infections start cocirculating in the communities.Competing Interest StatementThe authors declare the following competing interests. Dr. Sengupta is a consultant for HeartSciences, Kencor Health and Ultromics. The remaining authors declare no competing interests.Funding StatementThis work is supported in part by funds from the National Science Foundation (NSF: # 1920920) National Institute of General Medical Sciences of the National Institutes of Health under (NIH: #5U54GM104942-04). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study protocol was reviewed by the West Virginia University Institutional Review Board and ethical approval was given by WVU IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from WVU CTSI & TriNetX but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data is however available from the authors upon reasonable request and with permission of WVU CTSI & TriNetX. https://github.com/ynaveena/COVID-19-vs-Influenza